Basel, Switzerland

Robert James Weikert

This inventor holds 11 USPTO granted patents and 10 published patent applications and 6 EPO patents. Top assignees: Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag, European Molecular Biology Laboratory. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert James Weikert. Retrieved from https://idiyas.com/inventor/robert-james-weikert-ja8vurbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 27.3

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Basel, CH (2016 - 2018)
  • Clifton, NJ (US) (2016 - 2018)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert James Weikert

Introduction

Robert James Weikert is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of antiviral compounds, particularly in the treatment and prophylaxis of hepatitis B virus infection. With a total of 10 patents to his name, Weikert's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Weikert's latest patents include groundbreaking inventions such as "Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection." This invention provides novel compounds characterized by a specific general formula, which includes various defined variables. Additionally, he has developed antiviral compounds, disclosed in his patent titled "Antiviral compounds." This patent reveals compounds of Formula I, along with pharmaceutical compositions and methods for their use in preventing or treating HCV infection.

Career Highlights

Throughout his career, Weikert has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to significant advancements in antiviral therapies.

Collaborations

Weikert has collaborated with esteemed colleagues such as Elbert Chin and Qingjie Ding. These partnerships have further enriched his research and development efforts in the field of antiviral compounds.

Conclusion

Robert James Weikert's innovative work and numerous patents highlight his dedication to advancing antiviral therapies. His contributions continue to influence the pharmaceutical landscape, making a lasting impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…